David Jin - 01 Oct 2024 Form 4 Insider Report for Fortress Biotech, Inc. (FBIO)

Reporting relationship: Chief Financial Officer
Issuer ticker: FBIO
Reported as of: 01 Oct 2024
Net transaction value: +$3,224
SEC form: 4
Accepted by SEC: 01 Oct 2024, 16:15:07 UTC
Prior SEC filing: 25 Sep 2024
Next SEC filing: 29 Oct 2024
Source filing: View source filing
Reporting owner signature: /s/ David Jin

Key filing fact

David Jin filed Form 4 for Fortress Biotech, Inc. (FBIO) on 01 Oct 2024.

Key facts

This page summarizes David Jin's Form 4 filing for Fortress Biotech, Inc. (FBIO).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 01 Oct 2024, 16:15.

Change

Previous filing in this sequence was filed on 25 Sep 2024.
Current net transaction value: +$3,224.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

FBIO transaction

Common Stock, par value $0.001

Award

Transaction value: $3,224
Shares: +2,625
Change %: +1.1%
Price: $1.23
Shares after: 240,893
Date: 01 Oct 2024
Ownership: Direct
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

The reporting person is voluntarily reporting an acquisition of shares under the Issuer's Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Footnote F2

Total holdings include 230,000 shares underlying deferred restricted stock units.